Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

NCT01336933 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Anaplastic Large Cell Lymphoma
Angioimmunoblastic T-cell Lymphoma
Hepatosplenic T-cell Lymphoma
Peripheral T-cell Lymphoma

Interventions

DRUG: prednisone
DRUG: cyclophosphamide
DRUG: etoposide
DRUG: Vincristine
DRUG: pralatrexate
OTHER: laboratory biomarker analysis
GENETIC: comparative genomic hybridization
GENETIC: gene expression analysis
GENETIC: nucleic acid sequencing
GENETIC: mutation analysis
OTHER: immunohistochemistry staining method
GENETIC: microarray analysis
GENETIC: RNA analysis

Sponsor

University of Nebraska

Collaborators

[object Object]
[object Object]